Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|June 10, 2023
A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia CellsBarbara-Ann Guinn, Patrick J Schuler, Hubert Schrezenmeier, et al.
Journal of Clinical Medicine|November 27, 2019
The Important Role of Immunotherapies in Acute Myeloid LeukemiaJochen Greiner
British Journal of Haematology|July 8, 2022
Enhanced stimulation of antigen-specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti-programmed death 1 antibodyJochen Greiner, Marlies Goetz, Patrick J Schuler, et al.
Blood|May 18, 2012
Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemiaJochen Greiner, Yoko Ono, Susanne Hofmann, et al.
European Journal of Haematology|February 21, 2008
Leukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemiaJochen Greiner, Michael Schmitt
Haematologica|January 19, 2010
High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myelomaJochen Greiner, Anita Schmitt, Krzysztof Giannopoulos, et al.
Haematologica|December 6, 2006
Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigensJochen Greiner, Hartmut Döhner, Michael Schmitt
Virology Journal|July 22, 2009
Challenging complications of treatment--human herpes virus 6 encephalitis and pneumonitis in a patient undergoing autologous stem cell transplantation for relapsed Hodgkin's disease: a case reportMartin Bommer, Sandra Pauls, Jochen Greiner
International Journal of Molecular Sciences|March 25, 2022
Increasing Role of Targeted Immunotherapies in the Treatment of AMLJochen Greiner, Marlies Götz, Verena Wais
International Journal of Cancer|April 28, 2015
Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigensVanessa Schneider, Lu Zhang, Markus Rojewski, et al.
Pageof 9